AVITA Medical (RCEL) Operating Income (2018 - 2025)
AVITA Medical (RCEL) posted Operating Income of -$10.4 million for Q4 2025, down 13.71% on a QoQ basis from -$9.2 million in Q3 2025, and down 4.53% year-over-year from -$10.9 million in Q4 2024.
AVITA Medical (RCEL) Operating Income (2018 - 2025) Analysis & Trends
AVITA Medical's Operating Income history runs 8 years deep, the most recent figure standing at -$10.4 million for Q4 2025.
- Quarterly Operating Income fell 4.53% year-over-year to -$10.4 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$42.5 million (up 24.84% YoY) and the FY2025 annual result came in at -$42.5 million, up 24.84% from the prior year.
- Operating Income was -$10.4 million for Q4 2025 at AVITA Medical, down from -$9.2 million in the prior quarter.
- Across five years, Operating Income topped out at -$5.7 million in Q3 2022 and bottomed at -$17.2 million in Q1 2024.
- A 5-year average of -$11.1 million and a median of -$10.6 million in 2021 frame the typical range for Operating Income.
- Annual changes were most pronounced in 2022 — Operating Income soared 65.47% — and 2024, when it sank 73.61%.
- AVITA Medical's Operating Income stood at -$16.6 million in 2021, then soared by 40.52% to -$9.9 million in 2022, then decreased by 23.97% to -$12.3 million in 2023, then climbed by 18.87% to -$10.0 million in 2024, then decreased by 4.53% to -$10.4 million in 2025.
- Business Quant data shows RCEL's Operating Income at -$10.4 million in Q4 2025, -$9.2 million in Q3 2025, and -$11.1 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 1.35 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 936.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 1.87 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 1.10 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 477.60 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 255.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 282.15 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 515.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | AVITA Medical | 140.94 Mn | 124.59 Mn | 14.31 Mn | -10.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -10.41 Mn |
| Sep 30, 2025 | -9.15 Mn |
| Jun 30, 2025 | -11.15 Mn |
| Mar 31, 2025 | -11.83 Mn |
| Dec 31, 2024 | -9.96 Mn |
| Sep 30, 2024 | -13.81 Mn |
| Jun 30, 2024 | -15.62 Mn |
| Mar 31, 2024 | -17.21 Mn |
| Dec 31, 2023 | -12.27 Mn |
| Sep 30, 2023 | -9.31 Mn |
| Jun 30, 2023 | -11.17 Mn |
| Mar 31, 2023 | -9.91 Mn |
| Dec 31, 2022 | -9.90 Mn |
| Sep 30, 2022 | -5.75 Mn |
| Mar 31, 2022 | -9.49 Mn |
| Sep 30, 2021 | -16.64 Mn |
| Jun 30, 2021 | -10.70 Mn |
| Mar 31, 2021 | -5.99 Mn |
| Dec 31, 2020 | -5.63 Mn |
| Sep 30, 2020 | -10.21 Mn |